23andMe filed for bankruptcy in March 2025, raising concerns over its vast database of genetic and health data. A judge ruled the company could sell this data, prompting state attorneys general to advise consumers to delete their information. What does this mean for millions of users, and how does it impact future developments in genetics and privacy? Researchers at the University of Michigan are exploring these critical issues—read on to discover more.
